Mobile Site ›

The Use of Genetics in Guiding Therapy

Medco-Mayo Warfarin Effectiveness Study

Slide 16

June 2012

A fairly recent study evaluated hospitalization rates for patients beginning warfarin therapy with genotype-guided dosing as compared to historical controls without genotype-guided dosing. The study demonstrated that: Patients whose warfarin dosing was guided by genotype had 31% fewer hospitalizations for any reason. And hospital admissions for thromboembolism or bleeding were 28% less frequent in the genotyped group.

Medco-Mayo Warfarin Effectiveness Study


Jump to section: